| __timestamp | ImmunityBio, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1595000 | 1271353000 |
| Thursday, January 1, 2015 | 11434000 | 1620577000 |
| Friday, January 1, 2016 | 26546000 | 2052295000 |
| Sunday, January 1, 2017 | 39778000 | 2075142000 |
| Monday, January 1, 2018 | 53418000 | 2186100000 |
| Tuesday, January 1, 2019 | 111997000 | 3036600000 |
| Wednesday, January 1, 2020 | 139507000 | 2735000000 |
| Friday, January 1, 2021 | 195958000 | 2908100000 |
| Saturday, January 1, 2022 | 248149000 | 3592500000 |
| Sunday, January 1, 2023 | 232366000 | 4439000000 |
| Monday, January 1, 2024 | 5132000000 |
Infusing magic into the data realm
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Regeneron Pharmaceuticals, Inc. and ImmunityBio, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Regeneron consistently outspent ImmunityBio, with its R&D expenses growing from approximately $1.3 billion to $4.4 billion, marking a 240% increase. In contrast, ImmunityBio's R&D spending rose from a modest $1.6 million to $232 million, a staggering 14,400% increase, albeit from a much smaller base. This disparity highlights Regeneron's established market position and robust financial resources, while ImmunityBio's rapid growth underscores its aggressive push to innovate and compete. As these companies continue to invest in groundbreaking therapies, their R&D strategies will play a crucial role in shaping the future of healthcare.
Pfizer Inc. vs ImmunityBio, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Alnylam Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Summit Therapeutics Inc.
Regeneron Pharmaceuticals, Inc. or TG Therapeutics, Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Regeneron Pharmaceuticals, Inc. vs Viking Therapeutics, Inc.
Regeneron Pharmaceuticals, Inc. or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
R&D Insights: How Regeneron Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc. Allocate Funds
Analyzing R&D Budgets: Bio-Techne Corporation vs ImmunityBio, Inc.
Research and Development Expenses Breakdown: Pharming Group N.V. vs ImmunityBio, Inc.
Ultragenyx Pharmaceutical Inc. or ImmunityBio, Inc.: Who Invests More in Innovation?
Amicus Therapeutics, Inc. vs ImmunityBio, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Catalyst Pharmaceuticals, Inc. vs ImmunityBio, Inc.